Samlip Co., Ltd. (KRX:005610)
49,800
+200 (0.40%)
Last updated: Apr 29, 2026, 2:10 PM KST
Samlip Revenue
In the year 2025, Samlip had annual revenue of 3.37T KRW, down -1.68%. Samlip had revenue of 869.01B in the quarter ending December 31, 2025, a decrease of -3.73%.
Revenue
3,370.48B
Revenue Growth
-1.68%
P/S Ratio
0.12
Revenue / Employee
1.21B
Employees
2,791
Market Cap
402.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3,370.48B | -57.44B | -1.68% |
| Dec 31, 2024 | 3,427.92B | -5.40B | -0.16% |
| Dec 31, 2023 | 3,433.32B | 118.78B | 3.58% |
| Dec 31, 2022 | 3,314.55B | 367.89B | 12.49% |
| Dec 31, 2021 | 2,946.65B | 403.94B | 15.89% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Namyang Dairy Products | 914.15B |
| Pulmuone Corporate | 3,380.19B |
| EASY HOLDINGS | 3,388.90B |
| Daesang Holdings | 5,628.80B |
| Nongshim Holdings | 858.82B |
| Samyang | 2,562.50B |
| Kwang Dong Pharmaceutical | 1,659.51B |
| Sajodaerim | 3,499.81B |